BIRC5 and acute myeloid leukemia: These data show that targeting MUC1‐C with GO‐203 can potentially lead to a decrease in anti‐apoptotic properties in AML blasts via survivin down‐regulation, thereby rendering the tumour cells more susceptible to genotoxic damage.